TNDM Q3 2021 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$2B

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$180M+45.3% YoY

Gross Profit

$97M53.9% margin

Operating Income

$8M4.3% margin

Net Income

$6M3.2% margin

EPS (Diluted)

$0.09

QoQ Revenue Growth

+4.3%

Cash Flow

Operating Cash Flow

$34M

Free Cash Flow

$31M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$850M

Total Liabilities

$461M

Stockholders' Equity

$390M

Cash & Equivalents

$112M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$180M	$124M	+45.3%
Gross Profit	$97M	$65M	+48.1%
Operating Income	$8M	-$1M	+865.1%
Net Income	$6M	-$9M	+161.6%

Geographic Segments

UNITED STATES

$133M74%

Non-US

$47M26%